Joanna Harp, MD

Article

Distinguishing Generalized Bullous Fixed Drug Eruption From SJS/TEN: A Retrospective Study on Clinical and Demographic Features

Author:: Alexander S. Bang, MD; Nina R. Blank, MD; Joanna Harp, MD

Distinguishing features of generalized bullous fixed drug eruption (GBFDE) may include truncal and proximal predilection with early intertriginous...

Read More

Article

Retiform Purpura on the Buttocks in 6 Critically Ill COVID-19 Patients

Author:: Bukhtawar Waqas, BA; Fernanda Salgado, MD; Joanna Harp, MD

Retiform purpura in a severely ill patient with COVID-19 and a markedly elevated D-dimer concentration might be a cutaneous sign of systemic...

Read More

Article

Cutaneous Manifestations of COVID-19: Characteristics, Pathogenesis, and the Role of Dermatology in the Pandemic

Author:: Mariam Alam, MD; William Lewis, MD; Joanna Harp, MD; Katherine Steele, MD; Misha Rosenbach, MD; Robert G. Micheletti, MD

Cutaneous manifestations of COVID-19 may reflect the range of host immunologic responses to SARS-CoV-2.

Read More

Article

Papulonecrotic Tuberculid Secondary to Mycobacterium avium Complex

Author:: Brittany Urso, MD; Corey Georgesen, MD; Joanna Harp, MD

Papulonecrotic tuberculid (PNT) is the rarest form of cutaneous tuberculosis and rarely has been reported in connection to Mycobacterium avium...

Read More

Article

Hydralazine-Associated Cutaneous Vasculitis Presenting With Aerodigestive Tract Involvement

Author:: Laura Englander Levin, MD; Cynthia Magro, MD; James Horowitz, MD; Joanna Harp, MD

Hydralazine-induced small vessel vasculitis is a rare entity with a limited number of cases reported in the dermatologic literature...

Read More